4//SEC Filing
MOORE TIMOTHY L. 4
Accession 0001593968-23-000643
CIK 0001737287other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 5:20 PM ET
Size
6.7 KB
Accession
0001593968-23-000643
Insider Transaction Report
Form 4
MOORE TIMOTHY L.
Chief Technical Officer
Transactions
- Award
Common Stock
2023-04-24+186,219→ 186,219 total - Award
Stock Option (Right to Buy)
2023-04-24+831,024→ 831,024 totalExercise: $5.37Exp: 2033-04-24→ Common Stock (831,024 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option shall vest on April 24, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001669207
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 5:20 PM ET
- Size
- 6.7 KB